FrançaisAre analysts right about CME Group (CME)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For CME Group, we replayed every analyst price target of the past 12 months and measured the real outcome: 35% were profitable, average return +4% (173 calls). At 3 months: +0% average return (32% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Deutsche Bank | 29 | 48% | +13% |
| Rosenblatt | 18 | 6% | -13% |
| Citigroup | 17 | 47% | +12% |
| UBS | 16 | 25% | +8% |
| Oppenheimer | 14 | 36% | +8% |
Valuation
Is CME Group overvalued, and is it a good time to buy CME Group right now? If you're wondering, here's a recap to make up your own mind: CME Group's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price ÷ earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects — but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | CME Group | Sector median (Financials) |
|---|---|---|
| P/E | 23.8 | 14.0 |
| Forward P/E | 21.7 | 11.1 |
| Net margin | 63% | 24% |
👉 CME Group trades above its sector median (23.8 vs 14.0) — the market expects higher growth; watch out for disappointment.
📖 P/E, PEG, margin…: see the glossary
💵 Dividend : CME Group pays about $11.25/share/yr → 4.87% yield. what is this?
Frequently asked questions
Is CME Group a buy right now?
The analyst consensus on CME Group (CME) is "Hold" (24 bullish, 4 bearish calls over 12 months). This is not advice: historically, 35% of their targets on this stock turned out profitable over 1 year.
What is CME Group's price target?
The median 12-month price target is $270 (-4% vs $281), ranging from $230 to $330 (11 analysts).
Are analysts accurate on CME Group?
Over 1 year, 35% of analyst targets on CME Group were profitable, for an average return of +4% (across 173 timestamped calls). This is JPI Invest's accuracy metric.
What is the CME Group stock forecast?
Analysts target a median of $270 within 12 months, i.e. -4% vs the current price. The most bullish targets $330, the most cautious $230.
What is the CME Group stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $270, -4%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (35%), and the stock's past trajectory.
Is CME Group overvalued?
Its P/E is 23.8, forward P/E 21.7. A forward P/E lower than the current P/E means earnings are expected to grow.
📊 See the full interactive analysis of CME Group →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.